Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Patrice Cacoub and David Saadoun.
Patrice Cacoub
Connection Strength
11.172
David Saadoun
  1. Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis. Clin Gastroenterol Hepatol. 2019 02; 17(3):518-526.
    View in: PubMed
    Score: 0.770
  2. Impact of sustained virological response on the extrahepatic manifestations of chronic hepatitis C: a meta-analysis. Gut. 2018 11; 67(11):2025-2034.
    View in: PubMed
    Score: 0.765
  3. Effectiveness and cost of hepatitis C virus cryoglobulinaemia vasculitis treatment: From interferon-based to direct-acting antivirals era. Liver Int. 2017 12; 37(12):1805-1813.
    View in: PubMed
    Score: 0.718
  4. Rheumatologic Manifestations of Hepatitis C Virus Infection. Clin Liver Dis. 2017 08; 21(3):455-464.
    View in: PubMed
    Score: 0.713
  5. Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis. Gastroenterology. 2017 07; 153(1):49-52.e5.
    View in: PubMed
    Score: 0.708
  6. Response to: Cryoglobulinemic vasculitis in the era of direct-acting antiviral drug. Ann Rheum Dis. 2017 03; 76(3):e6.
    View in: PubMed
    Score: 0.692
  7. Role of matrix metalloproteinases, proinflammatory cytokines, and oxidative stress-derived molecules in hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum. 2007 Apr; 56(4):1315-24.
    View in: PubMed
    Score: 0.355
  8. Prevalence and clinical features of COVID-19 in a large cohort of 199 patients with sarcoidosis. Clin Exp Rheumatol. 2022 Jan-Feb; 40(1):195-196.
    View in: PubMed
    Score: 0.240
  9. SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study. Lancet Rheumatol. 2021 Jul; 3(7):e481-e488.
    View in: PubMed
    Score: 0.236
  10. Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward. Autoimmun Rev. 2021 Feb; 20(2):102729.
    View in: PubMed
    Score: 0.230
  11. Performance of serum apolipoprotein-A1 as a sentinel of Covid-19. PLoS One. 2020; 15(11):e0242306.
    View in: PubMed
    Score: 0.229
  12. Correspondence on 'Impact of COVID-19 pandemic on patients with large-vessels vasculitis in Italy: a monocentric survey'. Ann Rheum Dis. 2020 Nov 12.
    View in: PubMed
    Score: 0.228
  13. Neutrophil-Platelet and Monocyte-Platelet Aggregates in COVID-19 Patients. Thromb Haemost. 2020 12; 120(12):1733-1735.
    View in: PubMed
    Score: 0.228
  14. Prognostic Factors in Anti-glomerular Basement Membrane Disease: A Multicenter Study of 119 Patients. Front Immunol. 2019; 10:1665.
    View in: PubMed
    Score: 0.208
  15. TLR9 signalling in HCV-associated atypical memory B cells triggers Th1 and rheumatoid factor autoantibody responses. J Hepatol. 2019 11; 71(5):908-919.
    View in: PubMed
    Score: 0.208
  16. Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis. Autoimmun Rev. 2019 Jun; 18(6):621-626.
    View in: PubMed
    Score: 0.204
  17. Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients. Clin Immunol. 2018 12; 197:54-59.
    View in: PubMed
    Score: 0.195
  18. mTOR pathway activation in large vessel vasculitis. J Autoimmun. 2018 11; 94:99-109.
    View in: PubMed
    Score: 0.195
  19. Neuro-ophthalmological manifestations of Behçet's disease. Br J Ophthalmol. 2019 01; 103(1):83-87.
    View in: PubMed
    Score: 0.191
  20. [Ocular manifestations in Behçet's disease]. Rev Med Interne. 2018 Sep; 39(9):738-745.
    View in: PubMed
    Score: 0.190
  21. [Therapeutic strategy for the treatment of non-infectious uveitis proposed by an expert panel]. Rev Med Interne. 2018 Sep; 39(9):687-698.
    View in: PubMed
    Score: 0.190
  22. Large-vessel vasculitis in human immunodeficiency virus-infected patients. J Vasc Surg. 2018 05; 67(5):1501-1511.
    View in: PubMed
    Score: 0.186
  23. Severe infections in sarcoidosis: Incidence, predictors and long-term outcome in a cohort of 585 patients. Medicine (Baltimore). 2017 Dec; 96(49):e8846.
    View in: PubMed
    Score: 0.186
  24. Association of Prognostic Factors and Immunosuppressive Treatment With Long-term Outcomes in Neurosarcoidosis. JAMA Neurol. 2017 11 01; 74(11):1336-1344.
    View in: PubMed
    Score: 0.185
  25. Direct medical costs associated with the extrahepatic manifestations of hepatitis C virus infection in France. Aliment Pharmacol Ther. 2018 Jan; 47(1):123-128.
    View in: PubMed
    Score: 0.184
  26. Sarcoidosis with Takayasu arteritis: a model of overlapping granulomatosis. A report of seven cases and literature review. Int J Rheum Dis. 2018 Mar; 21(3):740-745.
    View in: PubMed
    Score: 0.182
  27. Investigational drugs in systemic vasculitis. Expert Opin Investig Drugs. 2017 Sep; 26(9):1049-1061.
    View in: PubMed
    Score: 0.182
  28. Cryoglobulinemia vasculitis: how to handle. Curr Opin Rheumatol. 2017 07; 29(4):343-347.
    View in: PubMed
    Score: 0.181
  29. Cardiac sarcoidosis: Diagnosis, therapeutic management and prognostic factors. Arch Cardiovasc Dis. 2017 Aug - Sep; 110(8-9):456-465.
    View in: PubMed
    Score: 0.179
  30. Anakinra in the Treatment of Patients with Refractory Scleritis: A Pilot Study. Ocul Immunol Inflamm. 2018; 26(6):915-920.
    View in: PubMed
    Score: 0.179
  31. Tocilizumab-Induced Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in Adult-Onset Still Disease. Ann Intern Med. 2017 Jul 18; 167(2):141-142.
    View in: PubMed
    Score: 0.179
  32. Management of severe complications in Behçet's disease with TNF inhibitors. Expert Opin Biol Ther. 2017 07; 17(7):853-859.
    View in: PubMed
    Score: 0.179
  33. Ustekinumab for Behçet's disease. J Autoimmun. 2017 Aug; 82:41-46.
    View in: PubMed
    Score: 0.179
  34. Cessation of oral anticoagulants in antiphospholipid syndrome. Lupus. 2017 Oct; 26(12):1291-1296.
    View in: PubMed
    Score: 0.178
  35. Direct-Acting Antiviral Therapy Restores Immune Tolerance to Patients With Hepatitis C Virus-Induced Cryoglobulinemia Vasculitis. Gastroenterology. 2017 06; 152(8):2052-2062.e2.
    View in: PubMed
    Score: 0.177
  36. Cardiac adipose tissue volume and IL-6 level at admission are complementary predictors of severity and short-term mortality in COVID-19 diabetic patients. Cardiovasc Diabetol. 2021 08 12; 20(1):165.
    View in: PubMed
    Score: 0.060
  37. [Differences of characteristics and outcomes between cancer patients and patients with no active cancer hospitalised for a SARS-CoV-2 infection]. Bull Cancer. 2021 Jun; 108(6):581-588.
    View in: PubMed
    Score: 0.058
  38. Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19. Therapie. 2021 Jul-Aug; 76(4):285-295.
    View in: PubMed
    Score: 0.058
  39. Development of a multivariate prediction model of intensive care unit transfer or death: A French prospective cohort study of hospitalized COVID-19 patients. PLoS One. 2020; 15(10):e0240711.
    View in: PubMed
    Score: 0.057
  40. Cytokine profile as a prognostic tool in coronavirus disease 2019. Comment on "Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome" by Quartuccio et al. Joint Bone Spine. 2020;87:191-93. Joint Bone Spine. 2021 01; 88(1):105074.
    View in: PubMed
    Score: 0.056
  41. Immunological and clinical effects of low-dose interleukin-2 across 11 autoimmune diseases in a single, open clinical trial. Ann Rheum Dis. 2019 02; 78(2):209-217.
    View in: PubMed
    Score: 0.050
  42. Clinical and multi-omics cross-phenotyping of patients with autoimmune and autoinflammatory diseases: the observational TRANSIMMUNOM protocol. BMJ Open. 2018 08 30; 8(8):e021037.
    View in: PubMed
    Score: 0.049
  43. Overall survival and mortality risk factors in Takayasu's arteritis: A multicenter study of 318 patients. J Autoimmun. 2019 01; 96:35-39.
    View in: PubMed
    Score: 0.049
  44. IL-2 antibodies in type 1 diabetes and during IL-2 therapy. Diabetologia. 2018 09; 61(9):2066-2068.
    View in: PubMed
    Score: 0.048
  45. Efficacy of tocilizumab in Takayasu arteritis: Multicenter retrospective study of 46 patients. J Autoimmun. 2018 07; 91:55-60.
    View in: PubMed
    Score: 0.048
  46. Accumulation of Antigen-Driven Lymphoproliferations in Complement Receptor 2/CD21-/low B Cells From Patients With Sjögren's Syndrome. Arthritis Rheumatol. 2018 02; 70(2):298-307.
    View in: PubMed
    Score: 0.047
  47. [Uveitis: Diagnostic work-up. Recommendations from an expert committee]. Rev Med Interne. 2018 Sep; 39(9):676-686.
    View in: PubMed
    Score: 0.046
  48. Uveitis: Diagnostic work-up. A literature review and recommendations from an expert committee. Autoimmun Rev. 2017 Dec; 16(12):1254-1264.
    View in: PubMed
    Score: 0.046
  49. Defective Early B Cell Tolerance Checkpoints in Sjögren's Syndrome Patients. Arthritis Rheumatol. 2017 11; 69(11):2203-2208.
    View in: PubMed
    Score: 0.046
  50. Long-Term Outcomes and Prognostic Factors of Complications in Takayasu Arteritis: A Multicenter Study of 318 Patients. Circulation. 2017 Sep 19; 136(12):1114-1122.
    View in: PubMed
    Score: 0.045
  51. International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus. Autoimmun Rev. 2017 Jun; 16(6):650-657.
    View in: PubMed
    Score: 0.045
  52. Efficacy and safety of tumor necrosis factor antagonists in refractory sarcoidosis: A multicenter study of 132 patients. Semin Arthritis Rheum. 2017 10; 47(2):288-294.
    View in: PubMed
    Score: 0.044
  53. International therapeutic guidelines for patients with HCV-related extrahepatic disorders. A multidisciplinary expert statement. Autoimmun Rev. 2017 May; 16(5):523-541.
    View in: PubMed
    Score: 0.044
  54. Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection. J Hepatol. 2017 06; 66(6):1282-1299.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.